Noticias de BTAI_US

Noticias del mercado

Últimas noticias sobre BTAI_US — 130 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: BTAI_US ✕ 130 resultados
16/03/2026 BTAI_US — Stock Titan
BioXcel Therapeutics (BTAI) officer converts 68 RSUs into common shares
16/03/2026 BTAI_US — Stock Titan ES ← EN
El director financiero de BioXcel Therapeutics (BTAI) ejerce RSU y eleva las tenencias directas a 6.645 acciones
12/03/2026 BTAI_US — Minichart
BioXcel Therapeutics Announces Registered Direct Offering and Warrant Amendment – SEC 8-K Filing March 2026
12/03/2026 BTAI_US — Hartford Business Journal
BioXcel Therapeutics raises $8M in stock offering
12/03/2026 BTAI_US — The Globe and Mail
BioXcel Therapeutics Announces Registered Direct Equity Financing
11/03/2026 BTAI_US — Investing.com
BioXcel Therapeutics raises $8M in registered direct offering By Investing.com
11/03/2026 BTAI_US — Yahoo Finance
BioXcel Therapeutics Announces Closing of $8.0 Million Registered Direct Offering
11/03/2026 BTAI_US — Stock Titan
AI-driven drugmaker BioXcel raises $8M, extends investor warrants
11/03/2026 BTAI_US — Investing.com
BioXcel Therapeutics closes $8M registered direct offering
11/03/2026 BTAI_US — The Manila Times
BioXcel Therapeutics Announces Approximately $8.0 Million Registered Direct Offering
10/03/2026 BTAI_US — GlobeNewswire
BioXcel Therapeutics Announces Approximately $8.0 Million Registered Direct Offering
10/03/2026 BTAI_US — Yahoo Finance
BioXcel Therapeutics Announces Approximately $8.0 Million Registered Direct Offering
10/03/2026 BTAI_US — Investing.com
BioXcel Therapeutics raises $8M in registered direct offering
06/03/2026 BTAI_US — Benzinga
Why Are BioXcel Therapeutics Shares Down Friday?
05/03/2026 BTAI_US — GlobeNewswire
BioXcel Therapeutics Announces Positive Phase 2 Topline
05/03/2026 BTAI_US — Stocktwits
BTAI Stock Gained 5% Today - What's The Latest On Its Opioid Withdrawal Treatment?
05/03/2026 BTAI_US — The Manila Times
BioXcel Therapeutics Announces Positive Phase 2 Topline Results from Columbia University-Led Study of BXCL501 for Treatment of Opioid Withdrawal
05/03/2026 BTAI_US — Yahoo Finance
BioXcel Therapeutics Announces Positive Phase 2 Topline Results from Columbia University-Led Study of BXCL501 for Treatment of Opioid Withdrawal
05/03/2026 BTAI_US — Stock Titan
Drug film BXCL501 eases opioid withdrawal in Columbia University study
05/03/2026 BTAI_US — GuruFocus
BioXcel Therapeutics (BTAI) Target Price Lowered by HC Wainwrigh

Página 6 de 7

keyboard_arrow_up